TG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituxima…
Biotechnology
US, New York [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | -1.00 | -1.00 | - - | -5.00 | -10.00 | -35.00 | -44.00 | -61.00 | -93.00 | -128.00 | -132.00 | -214.00 | -295.00 | -176.00 | -31.00 | |
| Operating Cash (Net) | -1.00 | -1.00 | - - | -5.00 | -10.00 | -35.00 | -44.00 | -61.00 | -93.00 | -128.00 | -132.00 | -214.00 | -295.00 | -176.00 | -31.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | 1.00 | -51.00 | |
| Accounts Payable | - - | - - | - - | - - | 4.00 | - - | 5.00 | 6.00 | 11.00 | 10.00 | -4.00 | 11.00 | 15.00 | -11.00 | - - | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | - - | - - | - - | 4.00 | -6.00 | 2.00 | 8.00 | 8.00 | 27.00 | 25.00 | -19.00 | -12.00 | -1.00 | -84.00 | |
| Other WC | - - | - - | - - | - - | - - | -5.00 | -3.00 | 2.00 | 8.00 | 27.00 | 29.00 | -31.00 | -10.00 | 7.00 | 3.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | - - | - - | - - | - - | -4.00 | -18.00 | -24.00 | 26.00 | -8.00 | 1.00 | - - | -24.00 | - - | -20.00 | -50.00 | |
| Capital Expenditure | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Purchases of Investments | - - | - - | - - | - - | -4.00 | -18.00 | -48.00 | -15.00 | -28.00 | -31.00 | -29.00 | -67.00 | -55.00 | -107.00 | -146.00 | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | 24.00 | 42.00 | 19.00 | 32.00 | 29.00 | 43.00 | 55.00 | 87.00 | 96.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 24.00 | - - | 19.00 | - - | |
| Other Investing Activities | - - | - - | - - | - - | -4.00 | -18.00 | -24.00 | 26.00 | -8.00 | 1.00 | - - | -24.00 | - - | -19.00 | -50.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | - - | -1.00 | -9.00 | -11.00 | -39.00 | -68.00 | -68.00 | -5.00 | -133.00 | -113.00 | -204.00 | -679.00 | -41.00 | - - | -72.00 | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -29.00 | - - | -30.00 | - - | -24.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | 37 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | 2.00 | 9.00 | - - | 37.00 | - - | - - | 4.00 | 131.00 | 113.00 | 175.00 | 679.00 | 2.00 | - - | 47.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 1.00 | - - | - - | 12.00 | 2.00 | 69.00 | 68.00 | - - | 2.00 | 113.00 | 58.00 | - - | 69.00 | - - | 49.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | - - | - - | - - | 9.00 | 16.00 | 40.00 | 55.00 | 55.00 | 25.00 | 57.00 | 43.00 | 113.00 | 554.00 | 300.00 | 102.00 | |
| End of Period | - - | - - | 9.00 | 16.00 | 40.00 | 55.00 | 55.00 | 25.00 | 56.00 | 43.00 | 113.00 | 554.00 | 300.00 | 103.00 | 92.00 | |
| Change | - - | - - | 9.00 | 6.00 | 24.00 | 15.00 | - - | -30.00 | 31.00 | -14.00 | 70.00 | 440.00 | -254.00 | -196.00 | -9.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Stock Based Compensation | - - | - - | - - | 3.00 | 5.00 | 21.00 | 15.00 | 7.00 | 15.00 | - - | 11.00 | 80.00 | 61.00 | 19.00 | 37.00 | |
| Other | 1.00 | -3.00 | - - | 16.00 | -9.00 | -4.00 | -5,836.00 | -5,836.00 | - - | 3.00 | 3.00 | 3.00 | 2.00 | 4.00 | 128.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -1.00 | -1.00 | - - | -5.00 | -10.00 | -35.00 | -44.00 | -61.00 | -93.00 | -129.00 | -132.00 | -214.00 | -296.00 | -176.00 | -31.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | - - | -55,875.00 | -79,207.00 | -110,458.00 | -38,882.00 | -36,123.00 | -10,618.00 | -57,875.00 | 113.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -66.00 |